Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$190,773
-$19,675 QoQ
Shares Held
1,510
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,921
of 2,266 holders
Holding Since
Dec 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BOWEN HANES & CO INC holds $152,182,717 across 7 Drug Manufacturers - General names. GILD ranks #7 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
114,646 | $137,509,863 | |
| 2 | JNJ |
Johnson & Johnson
|
36,439 | $9,254,412 | |
| 3 | ABBV |
AbbVie Inc.
|
12,440 | $3,130,401 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
16,445 | $947,560 | |
| 5 | PFE |
Pfizer Inc
|
35,984 | $866,494 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,204 | $283,214 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
1,510 | $190,773 |
All Filings in GILD
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $190,773 | 1,510 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $210,448 | 1,510 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $370,674 | 3,020 | Shares | Sole | 2026-02-10 | |
| 2024-06-30 | $309,431 | 4,510 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $652,291 | 8,905 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $721,394 | 8,905 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $289,643 | 3,865 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $737,174 | 9,565 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,031,520 | 24,485 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,525,983 | 17,775 | Shares | Sole | 2023-02-09 | |
| No filing history on record for this holder in this stock. | ||||||